Updated IGRA Test Guidelines for Latent Tuberculosis in Immunocompromised Patients
Berlin, Germany — Patients with weakened immune systems or those about to begin immunosuppressive treatments now face clearer guidance on how to assess their risk of latent tuberculosis infection (LTBI), thanks to updated recommendations from France’s Haute Autorité de Santé (HAS). The revised protocol, published in [June 2024](https://www.has-sante.fr/upload/docs/application/pdf/2024-06/avis_igra_2024.pdf) and effective immediately, expands the use of … Read more